🇺🇸 FDA
Patent

US 10118947

Modulation of structured polypeptide specificity

granted A61PA61P11/02A61P17/00

Quick answer

US patent 10118947 (Modulation of structured polypeptide specificity) held by BicycleRD Limited expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P11/02, A61P17/00, A61P17/04, A61P27/02